Literature DB >> 8616764

Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus.

S M Schwartz1, N S Weiss, J R Daling, M D Gammon, J M Liff, J Watt, C F Lynch, P A Newcomb, B K Armstrong, W D Thompson.   

Abstract

BACKGROUND: We analyzed data from a population-based, multi-center, case-control study to determine whether the occurrence of histologic types of uterine sarcoma is related to exogenous hormone use and/or to two correlates of endogenous estrogens: excess weight and cigarette smoking.
METHODS: One hundred sixty-seven women with newly-diagnosed uterine sarcoma (56 leiomyosarcoma, 85 mixed mullerian tumors, and 26 endometrial stromal sarcomas) were interviewed by telephone regarding possible risk factors for these neoplasms, For comparison, 208 women identified at random from the general population of the study areas were interviewed as controls.
RESULTS: Use of oral contraceptives was positively associated with the risk of leiomyosarcoma (odds ratios [OR] = 1.7, 95% confidence interval [CI] = 0.7, 4.1), primarily among women who last used these medications 15 or more years prior to diagnosis. Use of noncontraceptive estrogens was directly associated with the risk of mixed mullerian tumors, but only among recent and long-term users of these medications. Women in the highest quantile of body mass index (> or = 27.5 kg/m2) one year prior to diagnosis were at increased risk of each type of uterine sarcoma (leiomyosarcoma, OR = 2.5, 95% CI = 1.1, 5.7; mixed mullerian tumors, OR = 2.9, 95% CI = 1.3, 6.7; stromal sarcoma, OR = 3.5, 95% CI = 1.1, 10.9). Women who had ever smoked cigarettes were at reduced risk of leiomyosarcoma (OR = 0.6, 95% CI = 0.3, 1.1) and stromal sarcoma (OR = 0.5, 95% CI = 0.2, 1.2), but the relationship was not more pronounced among heavy smokers; no association with smoking was observed with mixed mullerian tumors.
CONCLUSIONS: Several of these findings parallel those from studies of endometrial carcinoma and may indicate a role for unopposed estrogen in the etiology of histologic types of uterine sarcoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616764     DOI: 10.1002/(sici)1097-0142(19960215)77:4<717::aid-cncr18>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Malignant mixed Mullerian tumors.

Authors:  J Ruiz Tovar; M E Reguero Callejas; J I Arano Bermejo; L F Capote Armas; F González-Palacios Martínez; L Cabañas Navarro
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

2.  Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway.

Authors:  Shucheng Chen; Lan Yao
Journal:  Cancer Chemother Pharmacol       Date:  2021-05-12       Impact factor: 3.333

Review 3.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  Surgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGG.

Authors:  M W Beckmann; I Juhasz-Böss; D Denschlag; P Gaß; T Dimpfl; P Harter; P Mallmann; S P Renner; S Rimbach; I Runnebaum; M Untch; S Y Brucker; D Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-02       Impact factor: 2.915

5.  Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma.

Authors:  Jasmine H Francis; Ruth A Kleinerman; Johanna M Seddon; David H Abramson
Journal:  Gynecol Oncol       Date:  2011-10-23       Impact factor: 5.482

Review 6.  MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation.

Authors:  Filipa Alves E Sousa; Joana Ferreira; Teresa Margarida Cunha
Journal:  Abdom Radiol (NY)       Date:  2021-09-01

7.  Relationships of uterine and ovarian tumors to pre-existing chronic conditions.

Authors:  Louise A Brinton; Lori C Sakoda; Kirsten Frederiksen; Mark E Sherman; Susanne K Kjaer; Barry I Graubard; Jorgen H Olsen; Lene Mellemkjaer
Journal:  Gynecol Oncol       Date:  2007-09-07       Impact factor: 5.482

8.  URI1 amplification in uterine carcinosarcoma associates with chemo-resistance and poor prognosis.

Authors:  Yu Wang; Michael J Garabedian; Susan K Logan
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

9.  Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis.

Authors:  Saketh R Guntupalli; Pedro T Ramirez; Matthew L Anderson; Michael R Milam; Diane C Bodurka; Anais Malpica
Journal:  Gynecol Oncol       Date:  2009-04-02       Impact factor: 5.482

10.  The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.

Authors:  A S Felix; L S Cook; M M Gaudet; T E Rohan; L J Schouten; V W Setiawan; L A Wise; K E Anderson; L Bernstein; I De Vivo; C M Friedenreich; S M Gapstur; R A Goldbohm; B Henderson; P L Horn-Ross; L Kolonel; J V Lacey; X Liang; J Lissowska; A Magliocco; M L McCullough; A B Miller; S H Olson; J R Palmer; Y Park; A V Patel; J Prescott; R Rastogi; K Robien; L Rosenberg; C Schairer; X Ou Shu; P A van den Brandt; R A Virkus; N Wentzensen; Y-B Xiang; W-H Xu; H P Yang; L A Brinton
Journal:  Br J Cancer       Date:  2013-01-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.